Saif, Muhammad Wasif. “MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients With Gemcitabine Refractory Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas 15, no. 3 (May 27, 2014): 278–279. Accessed April 20, 2025. https://serena.sharepress.it/index.php/jop/article/view/2507.